Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir monitoring of intrahepatic innate immune responses in chronic hepatitis B
NL-OMON33915Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tenofovir in Chronic Hepatitis B (CHB), sponsored by Erasmus MC. Primary endpoints: Peripheral blood NK cell frequency, phenotype, and function, Peripheral blood Treg and dendritic cell measurements and 4 more. Started Feb 2009; status: active, not recruiting.
02
Drugs
tenofovir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NL-OMON33915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33915.